Humatica wins prestigious Advisory Firm of the Year award in the People & Organisation Strategy category

ndetails

Humatica is pleased to announce that it received the Advisory Firm of the Year award in the People & Organisational Strategy category at Actum Group’s Private Equity Value Creation Awards dinner in London Mayfair on 16th March 2023.

Shortlisted alongside Korn Ferry, BCG and Alix Partners, the category invited submissions that highlighted work undertaken across portfolio companies covering people and organisational strategy initiatives. Humatica is the leading specialist in this area
and the team is thrilled to receive this accolade.

Andros Payne, Humatica Managing Partner, said: “After 20 years of dedicated focus on improving the organisational effectiveness of private equity portfolio companies, Actum’s award is a confirmation of our leadership in this space. Our data-driven tools and products enable operating partners, deal-teams and portfolio company leaders to align their organisations for success. Humatica’s productivity enhancement tools are setting the standard for improving efficiency and effectiveness.”

Related News

Experienced Private Equity executive Melissa Mounce joins Humatica to build the firm’s presence in the US
17 Feb., 2025 By Humatica

Experienced Private Equity executive Melissa Mounce joins Humatica to build the firm’s presence in the US

Humatica, the leading private equity specialist advisor for organizational effectiveness, is pleased to announce that Melissa Mounce has joined the firm as an Operating Partner…

Read more arrowicon
Humatica finalist for two prestigious PE Awards
03 Feb., 2025 By Humatica

Humatica finalist for two prestigious PE Awards

Humatica has been named a finalist for the Actum Awards as Value Creation Firm of the Year (People and Organisational Strategy) and for the Real Deals Private Equity Awards 2025 in…

Read more arrowicon
Humatica 2024 in Review and Outlook 2025
17 Dez., 2024 By Humatica

Humatica 2024 in Review and Outlook 2025

2024 was a milestone year for private equity, and for Humatica. The industry is under greater pressure to generate acceptable returns than ever before. With…

Read more arrowicon